S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Pardes Biosciences Inc (PRDS)
Pardes Biosciences Inc (PRDS) News

PRDS

Pardes Biosciences (PRDS)

Pardes Biosciences Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PRDS

1 2 3 4 5 Next >>

Date	Time	Source	Headline	Symbol	Company
09/11/2023	7:00AM	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:PRDS	Pardes Biosciences Inc
08/31/2023	4:17PM	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:PRDS	Pardes Biosciences Inc
08/31/2023	1:44PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRDS	Pardes Biosciences Inc
08/31/2023	1:32PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRDS	Pardes Biosciences Inc
08/31/2023	8:06AM	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:PRDS	Pardes Biosciences Inc
08/31/2023	8:03AM	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:PRDS	Pardes Biosciences Inc
08/31/2023	8:01AM	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:PRDS	Pardes Biosciences Inc
08/31/2023	7:59AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRDS	Pardes Biosciences Inc
08/31/2023	7:53AM	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NASDAQ:PRDS	Pardes Biosciences Inc
08/31/2023	7:34AM	Edgar (US Regulatory)	Form SC 13E3/A - Going private transaction by certain issuers: [Amend]	NASDAQ:PRDS	Pardes Biosciences Inc
08/31/2023	7:30AM	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:PRDS	Pardes Biosciences Inc
08/31/2023	7:15AM	GlobeNewswire Inc.	Pardes Biosciences Announces Closing of Tender Offer	NASDAQ:PRDS	Pardes Biosciences Inc
08/28/2023	11:11AM	Edgar (US Regulatory)	Form SC 13E3/A - Going private transaction by certain issuers: [Amend]	NASDAQ:PRDS	Pardes Biosciences Inc
08/28/2023	11:08AM	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:PRDS	Pardes Biosciences Inc
08/28/2023	10:52AM	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NASDAQ:PRDS	Pardes Biosciences Inc
08/28/2023	10:33AM	Business Wire	MediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes Biosciences	NASDAQ:PRDS	Pardes Biosciences Inc
08/17/2023	4:43PM	Business Wire	MediPacific Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Pardes Biosciences Shares	NASDAQ:PRDS	Pardes Biosciences Inc
08/17/2023	4:11PM	Edgar (US Regulatory)	Form SC 13E3/A - Going private transaction by certain issuers: [Amend]	NASDAQ:PRDS	Pardes Biosciences Inc
08/17/2023	4:09PM	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:PRDS	Pardes Biosciences Inc
08/17/2023	3:59PM	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NASDAQ:PRDS	Pardes Biosciences Inc
08/04/2023	3:03PM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PRDS	Pardes Biosciences Inc
08/04/2023	3:03PM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PRDS	Pardes Biosciences Inc
07/28/2023	4:08PM	Edgar (US Regulatory)	Form SC 13E3 - Going private transaction by certain issuers	NASDAQ:PRDS	Pardes Biosciences Inc
07/28/2023	4:04PM	Edgar (US Regulatory)	Form SC 14D9 - Solicitation, recommendation statements	NASDAQ:PRDS	Pardes Biosciences Inc
07/28/2023	4:01PM	Edgar (US Regulatory)	Form SC TO-T - Tender offer statement by Third Party	NASDAQ:PRDS	Pardes Biosciences Inc
07/17/2023	6:58AM	Edgar (US Regulatory)	Form SC TO-C - Written communication relating to an issuer or third party	NASDAQ:PRDS	Pardes Biosciences Inc
07/17/2023	6:55AM	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:PRDS	Pardes Biosciences Inc
07/17/2023	6:11AM	Edgar (US Regulatory)	Form SC14D9C - Written communication relating to third party tender offer	NASDAQ:PRDS	Pardes Biosciences Inc
07/17/2023	6:06AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRDS	Pardes Biosciences Inc
07/17/2023	6:00AM	GlobeNewswire Inc.	Pardes Biosciences Enters into Agreement to be Acquired by MediPacific, Inc. for between $2.02 and $2.19 in Cash per Share Plus Contingent Value Rights	NASDAQ:PRDS	Pardes Biosciences Inc

Showing the most relevant articles for your search:NASDAQ:PRDS

1 2 3 4 5 Next >>

Virexit Technologies (PK)

International Star (PK)

Cann American (CE)

RespireRx Pharmaceuticals (PK)

Ethema Health (PK)

Golden Triangle Ventures (PK)

Kraig Biocraft Laborator... (QB)

SMC Entertainment (PK)

Rennova Health (PK)

Ronn Motor (PK)

ERHC Energy (CE)

Hannover House (PK)

Anavex Life Sciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions